AG˹ٷ

STOCK TITAN

Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Negative)
Tags
conferences

Strata Critical Medical (NASDAQ:SRTA), previously Blade Air Mobility (NASDAQ:BLDE), has announced its participation in the upcoming 2025 Jefferies Industrials Conference. The company's Co-CEO and CFO, Will Heyburn, will deliver a presentation on September 4, 2025, at 11:30 AM ET.

Investors can access the presentation via webcast, with a replay available afterward on the company's investor relations website at ir.stratacritical.com/news-events.

Strata Critical Medical (NASDAQ:SRTA), precedentemente nota come Blade Air Mobility (NASDAQ:BLDE), ha comunicato la sua partecipazione alla Jefferies Industrials Conference 2025. Il Co-CEO e CFO Will Heyburn terrà una presentazione il 4 settembre 2025 alle 11:30 ET.

Gli investitori potranno seguire la presentazione via webcast; la registrazione sarà poi disponibile sul sito investor relations della società all'indirizzo ir.stratacritical.com/news-events.

Strata Critical Medical (NASDAQ:SRTA), anteriormente Blade Air Mobility (NASDAQ:BLDE), ha anunciado su participación en la Jefferies Industrials Conference 2025. El Co-CEO y CFO, Will Heyburn, ofrecerá una presentación el 4 de septiembre de 2025 a las 11:30 AM ET.

Los inversores podrán ver la presentación por webcast; la grabación estará disponible posteriormente en la web de relaciones con inversores de la compañía en ir.stratacritical.com/news-events.

Strata Critical Medical (NASDAQ:SRTA)(� Blade Air Mobility, NASDAQ:BLDE)� 2025 Jefferies Industrials Conference� 참가한다� 발표했습니다. 공동 CEO � CFO� � 헤이버른(Will Heyburn)� 2025� 9� 4� 오전 11:30(동부시간)� 발표� 진행합니�.

투자자들은 웹캐스트� 발표� 시청� � 있으�, 발표 � 회사 IR 사이� ir.stratacritical.com/news-events에서 재생 영상� � � 있습니다.

Strata Critical Medical (NASDAQ:SRTA), anciennement Blade Air Mobility (NASDAQ:BLDE), a annoncé sa participation à la Jefferies Industrials Conference 2025. Le co‑PDG et CFO, Will Heyburn, donnera une présentation le 4 septembre 2025 à 11h30 ET.

Les investisseurs pourront suivre la présentation en webcast ; un replay sera ensuite disponible sur le site relations investisseurs de la société à l'adresse ir.stratacritical.com/news-events.

Strata Critical Medical (NASDAQ:SRTA), zuvor Blade Air Mobility (NASDAQ:BLDE), hat seine Teilnahme an der Jefferies Industrials Conference 2025 angekündigt. Der Co-CEO und CFO Will Heyburn wird am 4. September 2025 um 11:30 Uhr ET eine Präsentation halten.

Investoren können die Präsentation per Webcast verfolgen; eine Aufzeichnung wird anschließend auf der Investor-Relations-Webseite der Gesellschaft unter ir.stratacritical.com/news-events verfügbar sein.

Positive
  • None.
Negative
  • None.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata� or the “Company�), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE) today announced that Will Heyburn, Co-Chief Executive Officer and Chief Financial Officer, will present at the 2025 Jefferies Industrials Conference on Thursday, Sept 4, 2025 at 11:30am ET. A webcast of the event will be available at the link . A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company’s website at .

About Strata Critical Medical

Strata Critical Medical provides time critical logistics solutions and specialized medical services to healthcare providers across the United States, strategically expanding its portfolio of services through acquisition and organic growth. Strata’s subsidiary, Trinity Medical Solutions, is an industry leader in air and ground transportation of human organs for transplant, leveraging Strata’s asset-light platform to reliably and efficiently deliver logistics solutions to its customers across the United States.

For more information, visit

Forward-Looking Statements

This press release contains “forward-looking statements� within the meaning of the “safe harbor� provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and may be identified by the use of words such as "will", “anticipate�, “believe�, “could�, “continue�, “expect", “estimate�, “may�, “plan�, “outlook�, “future�, "target", and “project� and other similar expressions and the negatives of those terms. These statements, which involve risks and uncertainties, relate to the sale of Strata's Passenger business, analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable and may also relate to Strata’s future prospects, developments and business strategies. In particular, such forward-looking statements include statements concerning the impact and anticipated benefits of the sale of Strata's Passenger business (including the receipt of any contingent consideration), the impact of such divestiture on Strata’s financial performance and liquidity outlook, Strata’s future plans and business strategies, financial and operating performance (including the discussion of financial and liquidity outlook and guidance for 2025 and beyond), the composition and performance of its fleet, results of operations, industry environment and growth opportunities and new product lines and partnerships. These statements are based on management’s current expectations and beliefs, as well as a number of assumptions concerning future events. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance.

Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Strata’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements include: unexpected costs, charges, or expenses resulting from the proposed divestiture; any failure to realize the anticipated efficiencies and benefits of such transaction; fluctuations in the value of any equity issued to Strata in the transaction; our continued incurrence of significant losses; failure of the markets for our offerings to grow as expected, or at all; our ability to successfully enter new markets and launch new routes and services; any adverse publicity stemming from accidents involving small aircraft, helicopters or charter flights and, in particular, any accidents involving our third-party operators; the impact of the recently completed sale of our Passenger business ; any change to the ownership of our aircraft and the challenges related thereto; the effects of competition; harm to our reputation and brand; our ability to provide high-quality customer support; our ability to maintain a high daily aircraft usage rate; changes in economic conditions; impact of natural disasters, outbreaks and pandemics, economic, social, weather, geopolitical, growth constraints, and regulatory conditions or other circumstances on metropolitan areas and airports where we have geographic concentration; the effects of climate change, including potential increased impacts of severe weather and regulatory activity; the availability of aircraft fuel; our ability to address system failures, defects, errors, or vulnerabilities in our website, applications, backend systems or other technology systems or those of third-party technology providers; interruptions or security breaches of our information technology systems; our placements within mobile applications; our ability to protect our intellectual property rights; our use of open source software; our ability to expand and maintain our infrastructure network; our ability to access additional funding; our ability to identify, complete and successfully integrate future acquisitions; our ability to manage our growth; increases in insurance costs or reductions in insurance coverage; the loss of key members of our management team; our ability to maintain our company culture; our reliance on contractual relationships with certain transplant centers and Organ Procurement Organizations; effects of fluctuating financial results; our reliance on third-party operators; the availability of third-party operators; disruptions to third-party operators; increases in insurance costs or reductions in insurance coverage for our third-party aircraft operators; the possibility that our third-party aircraft operators may illegally, improperly or otherwise inappropriately operate our branded aircraft; our reliance on third-party web service providers; changes in our regulatory environment; risks and impact of any litigation we may be subject to; regulatory obstacles in local governments; the expansion of domestic and foreign privacy and security laws; the expansion of environmental regulations; our ability to remediate any material weaknesses or maintain internal controls over financial reporting; our ability to maintain effective internal controls and disclosure controls; changes in the fair value of our warrants; and other factors beyond our control. Additional factors can be found in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, each as filed with the U.S. Securities and Exchange Commission. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and Strata undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, changes in expectations, future events or otherwise.

Contacts

Mathew Schneider


FAQ

When is Strata Critical Medical (SRTA) presenting at the 2025 Jefferies Industrials Conference?

Strata Critical Medical will present on Thursday, September 4, 2025 at 11:30 AM ET.

Who will represent Strata Critical Medical (SRTA) at the Jefferies Conference?

Will Heyburn, who serves as both Co-Chief Executive Officer and Chief Financial Officer, will represent the company.

How can investors access Strata Critical Medical's (SRTA) Jefferies Conference presentation?

Investors can access the presentation via live webcast, with a replay available afterward on the company's investor relations website at ir.stratacritical.com/news-events.

What was Strata Critical Medical's (SRTA) previous company name?

Strata Critical Medical was previously known as Blade Air Mobility, Inc. (NASDAQ: BLDE).
SRTA

:SRTA

SRTA Rankings

SRTA Latest News

SRTA Stock Data